Pages that link to "Q44240342"
Jump to navigation
Jump to search
The following pages link to A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis. (Q44240342):
Displaying 36 items.
- Anatomical and molecular imaging of skin cancer (Q30476227) (← links)
- Receptor-Mediated Melanoma Targeting with Radiolabeled α-Melanocyte-Stimulating Hormone: Relevance of the Net Charge of the Ligand (Q33603269) (← links)
- PET of malignant melanoma using 18F-labeled metallopeptides (Q34062271) (← links)
- 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression (Q34083332) (← links)
- Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog (Q34134418) (← links)
- Replacement of the Lys linker with an Arg linker resulting in improved melanoma uptake and reduced renal uptake of Tc-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide (Q34165263) (← links)
- Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake (Q34386219) (← links)
- Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analogues (Q34395062) (← links)
- Gallium-67-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide for primary and metastatic melanoma imaging (Q34436663) (← links)
- Substitution of the Lys linker with the β-Ala linker dramatically decreased the renal uptake of 99mTc-labeled Arg-X-Asp-conjugated and X-Ala-Asp-conjugated α-melanocyte stimulating hormone peptides (Q34525161) (← links)
- Radiofluorinated Rhenium Cyclized α-MSH Analogues for PET Imaging of Melanocortin Receptor 1 (Q34612830) (← links)
- Effects of the Amino Acid Linkers on the Melanoma-Targeting and Pharmacokinetic Properties of 111In-Labeled Lactam Bridge–Cyclized α-MSH Peptides (Q34728904) (← links)
- Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptake (Q35187053) (← links)
- Peptide-targeted radionuclide therapy for melanoma (Q35393994) (← links)
- Structural modification on the Lys linker enhanced tumor to kidney uptake ratios of 99mTc-labeled RGD-conjugated α-MSH hybrid peptides (Q35947223) (← links)
- Gallium-67-labeled lactam bridge-cyclized alpha-MSH peptides with enhanced melanoma uptake and reduced renal uptake (Q36230221) (← links)
- Cu-64-labeled lactam bridge-cyclized α-MSH peptides for PET imaging of melanoma (Q36346633) (← links)
- Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma. (Q36580750) (← links)
- Design and evaluation of new Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptides for melanoma imaging (Q36737564) (← links)
- 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging (Q36743097) (← links)
- Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy. (Q36753402) (← links)
- Design and development of molecular imaging probes (Q36785137) (← links)
- A practical guide to the construction of radiometallated bioconjugates for positron emission tomography. (Q37172093) (← links)
- Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide (Q37199680) (← links)
- Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH. (Q37364790) (← links)
- Evaluation of new Tc-99m-labeled Arg-X-Asp-conjugated α-melanocyte stimulating hormone peptides for melanoma imaging (Q37399483) (← links)
- Effects of amino acids on melanoma targeting and clearance properties of Tc-99m-labeled Arg-X-Asp-conjugated α-melanocyte stimulating hormone peptides. (Q37432511) (← links)
- Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide (Q37450632) (← links)
- Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers (Q38149131) (← links)
- Dual receptor-targeting ⁹⁹mTc-labeled Arg-Gly-Asp-conjugated Alpha-Melanocyte stimulating hormone hybrid peptides for human melanoma imaging (Q38921308) (← links)
- Melanoma targeting property of a Lu-177-labeled lactam bridge-cyclized alpha-MSH peptide (Q39183267) (← links)
- Substitution of Gly with Ala enhanced the melanoma uptake of technetium-99m-labeled Arg-Ala-Asp-conjugated alpha-melanocyte stimulating hormone peptide. (Q39403093) (← links)
- Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging (Q39635152) (← links)
- Melanoma targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[99mTc(CO)3]+: effect of cyclization on tumor-seeking properties. (Q40027123) (← links)
- Specific Targeting of Melanotic Cells with Peptide Ligated Photosensitizers for Photodynamic Therapy. (Q45199470) (← links)
- Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor (Q47135383) (← links)